Increased plasma corticosterone and decreased plasma thyroid stimulating hormone levels in rats treated with vincristine

L. Annunziato, G. F. Di Renzo, G. Schettini, U. Scapagnini, P. Preziosi

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

A single i.p. injection of vincristine (1000 μg/kg) into rats increased the plasma concentration of corticosterone after a latent period of 4 hr; the effect lasted for 48 hr. The response was dose related with the threshold dose being 100 μg/kg and the maximal effect occurring after 250 μg/kg. Vincristine also increased plasma corticosterone levels in hypophysectomized rats, suggesting that the drug may have a direct action on the adrenal gland. The injection of 500 or 1000 μg/kg also reduced the plasma concentration of thyroid-stimulating hormone. Twelve and 18 hr after the injection of vincristine (1000 μg/kg), the plasma concentration of thyroid-stimulating hormone was reduced, whereas the hypothalamic content of norepinephrine, a neurotransmitter involved in the regulation of thyrotropin-releasing hormone-thyroid-stimulating hormone secretion, remained unchanged. The adrenocortical stimulation produced by vincristine may play some role in the antineoplastic effects of this drug.

Original languageEnglish
JournalCancer Research
Volume37
Issue number8
Publication statusPublished - 1977

Fingerprint

Vincristine
Thyrotropin
Corticosterone
Injections
Thyrotropin-Releasing Hormone
Adrenal Glands
Antineoplastic Agents
Neurotransmitter Agents
Norepinephrine
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Increased plasma corticosterone and decreased plasma thyroid stimulating hormone levels in rats treated with vincristine. / Annunziato, L.; Di Renzo, G. F.; Schettini, G.; Scapagnini, U.; Preziosi, P.

In: Cancer Research, Vol. 37, No. 8, 1977.

Research output: Contribution to journalArticle

@article{dbdc7d2b00df438cb24860dfec3b9720,
title = "Increased plasma corticosterone and decreased plasma thyroid stimulating hormone levels in rats treated with vincristine",
abstract = "A single i.p. injection of vincristine (1000 μg/kg) into rats increased the plasma concentration of corticosterone after a latent period of 4 hr; the effect lasted for 48 hr. The response was dose related with the threshold dose being 100 μg/kg and the maximal effect occurring after 250 μg/kg. Vincristine also increased plasma corticosterone levels in hypophysectomized rats, suggesting that the drug may have a direct action on the adrenal gland. The injection of 500 or 1000 μg/kg also reduced the plasma concentration of thyroid-stimulating hormone. Twelve and 18 hr after the injection of vincristine (1000 μg/kg), the plasma concentration of thyroid-stimulating hormone was reduced, whereas the hypothalamic content of norepinephrine, a neurotransmitter involved in the regulation of thyrotropin-releasing hormone-thyroid-stimulating hormone secretion, remained unchanged. The adrenocortical stimulation produced by vincristine may play some role in the antineoplastic effects of this drug.",
author = "L. Annunziato and {Di Renzo}, {G. F.} and G. Schettini and U. Scapagnini and P. Preziosi",
year = "1977",
language = "English",
volume = "37",
journal = "Journal of Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "8",

}

TY - JOUR

T1 - Increased plasma corticosterone and decreased plasma thyroid stimulating hormone levels in rats treated with vincristine

AU - Annunziato, L.

AU - Di Renzo, G. F.

AU - Schettini, G.

AU - Scapagnini, U.

AU - Preziosi, P.

PY - 1977

Y1 - 1977

N2 - A single i.p. injection of vincristine (1000 μg/kg) into rats increased the plasma concentration of corticosterone after a latent period of 4 hr; the effect lasted for 48 hr. The response was dose related with the threshold dose being 100 μg/kg and the maximal effect occurring after 250 μg/kg. Vincristine also increased plasma corticosterone levels in hypophysectomized rats, suggesting that the drug may have a direct action on the adrenal gland. The injection of 500 or 1000 μg/kg also reduced the plasma concentration of thyroid-stimulating hormone. Twelve and 18 hr after the injection of vincristine (1000 μg/kg), the plasma concentration of thyroid-stimulating hormone was reduced, whereas the hypothalamic content of norepinephrine, a neurotransmitter involved in the regulation of thyrotropin-releasing hormone-thyroid-stimulating hormone secretion, remained unchanged. The adrenocortical stimulation produced by vincristine may play some role in the antineoplastic effects of this drug.

AB - A single i.p. injection of vincristine (1000 μg/kg) into rats increased the plasma concentration of corticosterone after a latent period of 4 hr; the effect lasted for 48 hr. The response was dose related with the threshold dose being 100 μg/kg and the maximal effect occurring after 250 μg/kg. Vincristine also increased plasma corticosterone levels in hypophysectomized rats, suggesting that the drug may have a direct action on the adrenal gland. The injection of 500 or 1000 μg/kg also reduced the plasma concentration of thyroid-stimulating hormone. Twelve and 18 hr after the injection of vincristine (1000 μg/kg), the plasma concentration of thyroid-stimulating hormone was reduced, whereas the hypothalamic content of norepinephrine, a neurotransmitter involved in the regulation of thyrotropin-releasing hormone-thyroid-stimulating hormone secretion, remained unchanged. The adrenocortical stimulation produced by vincristine may play some role in the antineoplastic effects of this drug.

UR - http://www.scopus.com/inward/record.url?scp=0017646715&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017646715&partnerID=8YFLogxK

M3 - Article

C2 - 872085

AN - SCOPUS:0017646715

VL - 37

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0008-5472

IS - 8

ER -